Search results for:
triptorelin
triptorelin
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Triptodur |
KIT, INJECTABLE |
22.5 mg |
|
|
|
|
Trelstar Mixject |
POWDER FOR INJECTION, INTRAMUSCULAR |
3.75 mg/4 weeks |
|
|
|
|
Trelstar Mixject |
POWDER FOR INJECTION, INTRAMUSCULAR |
11.25 mg/12 weeks, 22.5 mg/24 weeks |
|
|
|
|
Last updated: Oct. 4, 2023
- HAZ-MED: Group 1
- Formulary, Not Routinely Stocked:
- Hormonal Therapy: This drug is a hormonal therapy in used in oncologic conditions. This drug may be resumed by a hospitalist or non-oncology healthcare provider without contacting an oncology pharmacy specialist or consulting an oncologist.
Trelstar was approved as a formulary agent, but the prescriber should be strongly encouraged to initiate and administer the drug in the outpatient setting where the reimbursement is better.
If necessary to administer to an inpatient, only the 3.75 mg dose (which covers about 4 weeks) should be given. It will not be generally stocked, but a dose can be ordered in if needed.
Triptodur is non-formulary. Defer initiation to after discharge.
Reviewed: October 26, 2010, & 27 Feb 2018 (Triptodur)